Item 5.02 Departure of Directors or Certain Officers; Election of Directors;


          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers.



On September 9, 2020, the Compensation Committee of the Board of Directors of
Hologic, Inc. ("Hologic" or the "Company") approved the Company's entry into a
new Severance and Change of Control Agreement (the "Severance and Change of
Control Agreement") with Kevin R. Thornal, Division President, Diagnostics,
which supersedes in its entirety Mr. Thornal's Division President Severance
Agreement dated July 20, 2017, and his Change of Control Agreement dated July
20, 2017.
The Severance and Change of Control Agreement, which is the Company's standard
form of agreement for Senior Executive Officers, is substantially similar to Mr.
Thornal's prior agreement, except in the event he is entitled to severance
pursuant to the terms of the agreement, rather than a 15-month base salary
continuation, he is now entitled to a 12-month base salary continuation, an
amount equal to his three-year average annual bonus and a 1-year welfare benefit
continuation. In the context of Change of Control, Mr. Thornal's new agreement
provides for a cash payment equal to 2.99 times his annual base salary and
highest annual bonus rather than a cash payment equal to 1 times his base salary
and average annual bonus.
The foregoing description of Mr. Thornal's new Severance and Change of Control
Agreement is qualified in its entirety by reference to the full text of the
agreement, which is filed with this Current Report on Form 8-K as Exhibit 10.1
and incorporated herein by reference.


Exhibit
Number    Description

            Severance and Change of Control Agreement dated September 15, 2020 by
 10.1     and between Kevin R. Thornal and Hologic, Inc.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses